Mevalonate Kinase Deficiency

1

Review clinical trials related to Mevalonate Kinase Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency

Mevalonate kinase deficiency (HyperIgD syndrome, HIDS) is an inborn error of immunity caused by a block in the mevalonate pathway. The subsequent lack of isoprenoids with antiinflammatory properties might contribute to the autoinflammatory nature of the disease. A pilot study aims to verify the safety and efficacy of the dietary supplement Geranylgeraniol, aiming at a mitigation of isoprenoids deficiency caused by the above-mentioned block in the MVK pathway.

Participants needed: 6
Trial details
Age: 12+Biological sex: AllType: InterventionalSponsor: University Hospital, MotolUpdated: Jul 12, 2024Locations: 1
Eligibility criteria

Patients older than 12 years with genetically confirmed MVK deficiency [+3]